Literature DB >> 10547072

Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis.

R C Humphreys1, L Hennighausen.   

Abstract

The mammary gland undergoes extensive tissue remodeling and cell death at the end of lactation in a process known as involution. We present evidence that the prolactin-activated transcription factor signal transducer and activator of transcription 5a (Stat5a) has a crucial role in the regulation of cell death during mammary gland involution. In a transforming growth factor-alpha transgenic mouse model that exhibited delayed mammary gland involution, the absence of Stat5a facilitated involution-associated changes in morphology of the gland and the extent and timing of programmed cell death. These Stat5a-dependent changes also affected epidermal growth factor receptor-initiated mammary gland tumorigenesis. Overexpression of the transforming growth factor alpha transgene in the mammary epithelium reproducibly generated mammary hyperplasia and tumors. In the presence of the activated epidermal growth factor receptor, deletion of Stat5a delayed initial hyperplasia and mammary tumor development by 6 weeks. These observations demonstrate that Stat5a is a survival factor, and its presence is required for the epithelium of the mammary gland to resist regression and involution-mediated apoptosis. We also suggest that Stat5a is one of the antecedent, locally acting molecules that initiate the process of epithelial regression and reorganization during involution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10547072

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  39 in total

1.  The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.

Authors:  Ji Hoon Yu; Bing-Mei Zhu; Mark Wickre; Gregory Riedlinger; Weiping Chen; Atsushi Hosui; Gertraud W Robinson; Lothar Hennighausen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

2.  HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.

Authors:  Terry R Medler; Justin M Craig; Alyson A Fiorillo; Yvonne B Feeney; J Chuck Harrell; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

3.  Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Ginger A Stringer; Alexander C Klimowicz; Edward Pequignot; Boris Freydin; Thai H Tran; Ning Yang; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Marja T Nevalainen; Craig D Shriver; Terry Hyslop; Guido Sauter; David L Rimm; Anthony M Magliocco; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

Review 4.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 5.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

6.  A functional and regulatory network associated with PIP expression in human breast cancer.

Authors:  Marie-Anne Debily; Sandrine El Marhomy; Virginie Boulanger; Eric Eveno; Régine Mariage-Samson; Alessandra Camarca; Charles Auffray; Dominique Piatier-Tonneau; Sandrine Imbeaud
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

7.  Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.

Authors:  K Sakamoto; A A Triplett; L A Schuler; K-U Wagner
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

8.  Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.

Authors:  Tali Eilon; Itamar Barash
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

9.  Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.

Authors:  Priya Koppikar; Vivian Wai Yan Lui; David Man; Sichuan Xi; Raymond Liu Chai; Elizabeth Nelson; Allison B J Tobey; Jennifer Rubin Grandis
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Authors:  Zsuzsanna S Nagy; Matthew J LeBaron; Jeremy A Ross; Abhisek Mitra; Hallgeir Rui; Robert A Kirken
Journal:  Mol Cancer       Date:  2009-08-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.